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Introduction {#sec1}
============

Epigenetic regulations, which include DNA methylation, genomic imprinting, RNA editing, and histone modification, have been reported playing critical roles in almost every biological process ([@bib5]; [@bib18]; [@bib41]). Trimethylation of histone H3 at lysine 27 (H3K27me3) is believed to be a repressive epigenetic mark for maintaining transcriptional gene silencing ([@bib38]). In mammals, the dynamic steady-state levels of di-methylation and tri-methylation of histone H3 lysine 27 (H3K27me2/3) are mainly regulated by the balance between the methyltransferase polycomb repressor complex 2 (PRC2) and the histone demethylases *UTX* (also known as *KDM6A*) and *JMJD3* (also known as *KDM6B*) ([@bib1]; [@bib22]; [@bib28]; [@bib39]). Trimethylated histone H3 lysine 27 (H3K27me3) is critical for wound repair, skeleton growth, and cell fate determination ([@bib10]; [@bib43]; [@bib48]). Meanwhile, the JMJC domain protein *UTX* acts as an H3K27-specific demethylases that remove this H3K37me mark, enabling the activation of genes involved in cancer, germ cell epigenetic reprogramming, and inflammation ([@bib12]; [@bib20]; [@bib26]).

H3K27me3 is a mark of gene repression, while H3K4me3 is a mark of gene activation. These two marks denoting opposite gene expression states co-localize at many differentiation-specific gene promoters in stem cells to form bivalent promoters in which they are located at different H3 tails in nucleosomes ([@bib6]; [@bib29]). The H3K4 methyltransferase mixed-lineage leukemia 2 (*MLL2*; also known as *KMT2B*) is important for the formation of H3K4me3 in bivalent domains, and the H3K4 methyltransferase *MLL1* plays a redundant role in depositing H3K4me3 to generate bivalent domains ([@bib8]; [@bib15]). Besides, the H3K27 methyltransferase complex PRC2 and H3K4 methyltransferases *SET1A* and *SET1B* are associated with the generation of bivalency ([@bib42]). However, we still know very little about which histone methylation modifier is responsible for the resolution of bivalent domains into active monovalent states during human neural differentiation.

Previous studies have demonstrated that the regulation of H3K27me3 is absolutely indispensable for the development and function of the mammalian nervous system ([@bib2]; [@bib3]; [@bib13]; [@bib24]). For example, *Ezh2*, a histone methyltransferase of PRC2, is essential for controlling the rate at which cortical progenitor cells proliferate and differentiate into lineage cells, and loss of *Ezh2* results in a removal of the repressive mark of H3K27me3 in cortical progenitor cells and a decline in terminally differentiated neurons ([@bib34]). During neocortical development, the polycomb group complex restricts neurogenic competence of neural progenitor cells (NPCs) and promotes the fate transition of NPCs from neurogenic to astrogenic ([@bib14]). *UTX* is broadly expressed in various regions of the mouse brain ([@bib45]), and its mutations are associated with Kabuki syndrome whose patients have developmental delay and intellectual disability ([@bib30]). In addition, *UTX* has also been demonstrated to be the promotional transcription factor of *Pten* by demethylating H3K27me3 at the *Pten* promoter to control neurogenesis in mice ([@bib23]). However, some other findings suggest that the H3K27me demethylase activity of *UTX* is dispensable for the development of the nervous system. For instance, Kabuki causative point mutations upstream of the JmjC domain do not destroy *UTX* demethylation ([@bib37]). In addition, deletion of *UTX* does not affect global H3K27me levels in neural crest cells ([@bib37]). Therefore, whether the regulation mechanism of *UTX* in neurodevelopment depends on its demethylase function remains to be investigated.

In our previous study, we found that specific deletion of *UTX* in the mouse forebrain results in aberrant dendrite complexity and abnormal synaptic plasticity, and H3K27me3 level increased in the hippocampus of *UTX* knockout (KO) mice ([@bib40]). However, the role and mechanism of *UTX* in human neural morphogenesis and development have not yet been elucidated. In this study, we investigated the role of *UTX* in neural progenitors and neurons differentiated from human embryonic stem cells (hESCs). We found that *UTX* was upregulated upon neural differentiation of hESCs, and loss of *UTX* in hESCs led to the decline in their differentiation potential into neurons, the decrease of neurite complexity, and the defect of electrophysiological function. Finally, we provided evidence showing that *UTX* regulated human neural differentiation and dendritic morphology of neurons by resolving bivalent promoter dependent on its H3K27 demethylase activity.

Results {#sec2}
=======

*UTX* Is Enriched in Human NPCs during Differentiation of hESCs into Neurons {#sec2.1}
----------------------------------------------------------------------------

To investigate the expression of *UTX* and H3K27me3 during human neural differentiation, we utilized an *in vitro* culture system to differentiate hESCs into human neural stem cells (hNSCs), human neural progenitor cells (hNPCs), and neurons ([Figure 1](#fig1){ref-type="fig"}A). Real-time RT-PCR analysis showed that the mRNA expression of *UTX* was not abundant in hESCs, but was increased in hNSCs and hNPCs ([Figure 1](#fig1){ref-type="fig"}B). Consistent with this, higher protein levels of *UTX* in hNSCs and hNPCs were also detected by western blotting ([Figure 1](#fig1){ref-type="fig"}C). Although *UTX* is known to have histone demethylase activity, both immunofluorescence and western blotting assays demonstrated that the expression levels of both H3K27me3 and *UTX* were also significantly increased during the neural differentiation of hESCs ([Figures 1](#fig1){ref-type="fig"}D and 1E). Meanwhile, the expression of H3K27ac was declined by almost 30% in hNSCs and hNPCs ([Figure 1](#fig1){ref-type="fig"}E). These results suggested that *UTX* might play an important role in neural differentiation of hESCs.Figure 1*UTX* Is Upregulated in Earlier Stages of Neural Differentiation of hESCs(A) Schematic illustration of neural differentiation of hESCs. hESCs, human embryonic stem cells; EB, embryoid bodies; hNSCs, human neural stem cells; hNPCs, human neural progenitor cells. Scale bar, 50 μm.(B) Real-time PCR analysis showing higher mRNA levels of *UTX* in earlier stages of neural differentiation of hESCs. *GAPDH* is used as an internal control for real-time PCR.(C) Western blotting indicating upregulated protein levels of *UTX* at earlier stages during neural differentiation of hESCs. β-Tubulin is used as a loading control.(D) Representative images of H3K27me3 immunostaining at different stages of neural differentiation of hESCs. DAPI, a nuclei marker; *Nestin*, an NSC marker; *DCX*, an NPCs marker; *MAP2*, a mature neuron marker. Scale bar, 50 μm.(E) Western blotting showing protein levels of H3K27me3 and H3K27ac upon neural differentiation of hESCs. Histone 3 was used as a loading control.Results are presented as mean ± SEM; n ≥ 3 independent experiments. ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001.

The Expression of H3K27me3 Is Not Altered in *UTX* KO hESCs {#sec2.2}
-----------------------------------------------------------

To explore the function of UTX in neural differentiation of hESCs, we conducted CRISPR/Cas9-mediated gene editing to knock out *UTX* in hESCs. We successfully established two *UTX*-null hESC clones (KO1, KO2) ([Figure 2](#fig2){ref-type="fig"}A). Two specific single-guide RNA (sgRNAs) targeting exon 1 of *UTX* were designed (as shown in [Figure 2](#fig2){ref-type="fig"}A and at the Optimized CRISPR Design website <http://crispr.mit.edu>) ([@bib7]). Off-target effect was not detected in six potential genes that were predicted by the Optimized CRISPR Design tool, indicating the specificity of the selected sgRNAs ([Figure S1](#mmc1){ref-type="supplementary-material"}A).Figure 2Generation and Characterization of *UTX* Knockout hESCs(A) CRISPR sgRNA sequences and mutations in two *UTX* knockout clones (KO1, KO2). The sgRNA sequences are labeled in blue and PAM recognition sequences are highlighted in red. Light-colored sequences indicating the deletion of allele 1 (al1) and allele 2 (al2). WT, wild type.(B) Western blotting demonstrating that UTX protein is undetectable in both *UTX* KO clones.(C) Real-time PCR analysis confirming the mutation of *UTX* in both *UTX* KO clones.(D) Representative images of *UTX* immunostaining of *UTX* KO hESCs. Scale bar, 20 μm.(E) Western blotting indicating normal protein expression of H3K27me3 in *UTX* KO clones. Histone 3 was used as a loading control.(F) Representative images of H3K27me3 immunostaining showing its unaltered expression in *UTX* KO clones. Results are presented as mean ± SEM; n = 3 independent experiments. ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001.

To confirm the deletion of *UTX* in hESCs, we performed western blotting, RT-PCR, and immunofluorescent staining analyses of *UTX* KO clones. Compared with wild-type (WT) cells, we observed a complete loss of UTX protein both in KO1 and KO2 hESCs ([Figures 2](#fig2){ref-type="fig"}B and 2D). Consistent with this, the mRNA expression of *UTX* was almost undetectable in *UTX* KO hESCs ([Figure 2](#fig2){ref-type="fig"}C). Next, we examined the expression of H3K27me3 in *UTX* KO hESCs, and found that H3K27me3 was unchanged upon the deletion of *UTX* in hESCs ([Figures 2](#fig2){ref-type="fig"}E and 2F). Besides, the expression of *JMJD3*, another H3K27me3 demethylase, was not changed in *UTX* KO hESCs ([Figure S1](#mmc1){ref-type="supplementary-material"}B) and two *UTX* knockout cell lines had a normal karyotype ([Figure S1](#mmc1){ref-type="supplementary-material"}C). In summary, these observations supported the idea that UTX might play roles independent of its histone lysine demethylase activity in hESCs.

Deletion of *UTX* Has No Effects on Pluripotency and Self-Renewal of hESCs {#sec2.3}
--------------------------------------------------------------------------

To confirm the pluripotency status of the established *UTX* KO hESC clones, we examined the expression of several markers for stemness and cell proliferation. We observed similar expression levels of pluripotency markers in *UTX* WT and KO cell lines by immunofluorescence staining, qPCR, and western blotting ([Figures S2](#mmc1){ref-type="supplementary-material"}A--S2C). *UTX* WT and KO cells also displayed similar proliferation potentials by 5-bromo-2′-deoxyuridine (BrdU) incorporation and PH3S10 immunofluorescent staining analyses ([Figures S3](#mmc1){ref-type="supplementary-material"}A and S3B). These results suggested that *UTX* deletion did not affect pluripotency or self-renewal of hESCs.

*UTX* Is Required for Neural Differentiation of hESCs {#sec2.4}
-----------------------------------------------------

We next induced hESCs to differentiate toward hNSCs to investigate the function of *UTX* during early neural differentiation of hESCs. At day 14 after neural differentiation, both *UTX* WT and KO hNSCs could express the typical neural progenitor-specific markers *PAX6* and *Nestin*, with no discernible difference in the percentage of *PAX6*^+^ or the fluorescence of *Nestin*^+^ cells ([Figures S4](#mmc1){ref-type="supplementary-material"}A--S4C). RT-PCR results then confirmed that both *UTX* WT and KO hNSCs had the same mRNA expression levels of *PAX6* and *Nestin* ([Figure S4](#mmc1){ref-type="supplementary-material"}E).

Quantification of BrdU^+^ cells after pulse labeling indicated that *UTX* loss of function had no obvious effect on the proportion of BrdU^+^ cells compared with WT hNSCs ([Figures S4](#mmc1){ref-type="supplementary-material"}A and S4D). However, at day 40 after neural differentiation, we observed decreased numbers of *MAP2*^+^ neurons and *Tuj1*^+^ neurons in both *UTX* KO clones ([Figures 3](#fig3){ref-type="fig"}A and 3B), indicating that *UTX* loss of function decreased neural differentiation efficiency of hNSCs. Moreover, our RT-PCR analysis showed a significant decrease in mRNA expression levels of *MAP2* and *TUJ1* in *UTX* KO cells compared with WT control at day 40 after neural differentiation of hESCs ([Figure 3](#fig3){ref-type="fig"}C), further proving that deletion of *UTX* inhibited neural differentiation of hESCs.Figure 3*UTX* Loss-of-function Inhibits Neural Differentiation of hESCs(A) Immunostaining of neuron markers *MAP2* and *Tuj1* at day 40 of neural differentiation. Scale bar, 20 μm.(B) Quantitative analysis showing reduced percentages of *MAP2*^+^ and *Tuj1*^+^ neurons derived from *UTX* KO hESCs.(C) qRT-PCR analysis showing that the expression levels *MAP2* and *Tuj1* were significantly lower in *UTX* KO cells at day 40 of neural differentiation. Results are presented as mean ± SEM; n = 3 independent experiments. ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001.

Loss of *UTX* Results in Decreased Neurite Complexity and Electrophysiological Defects in hESC-Derived Neurons {#sec2.5}
--------------------------------------------------------------------------------------------------------------

We next determined whether the loss of *UTX* affected neurite growth of hESC-derived neurons. Morphology analysis showed that *UTX* KO hESC-derived neurons exhibited a significant reduction in neurite complexity with decrease in total neurite length, and numbers of nodes and ends, compared with WT neurons at day 40 after neural differentiation ([Figures 4](#fig4){ref-type="fig"}A--4E).Figure 4Loss of *UTX* Results in Decreased Neurite Complexity and Electrophysiological Defects of hESC-Derived Neurons(A) Representative images of neurons derived from *UTX* WT and KO hESCs at day 40 of neural differentiation.(B) Sholl analysis showing that total neurite length reduced in *UTX* KO hESC-derived neurons (60 neurons in every group in 3 independent experiments).(C--E) Compared with WT group, *UTX* KO hESC-derived neurons exhibited decreased dendritic complexity as shown in reduced numbers of intersections (C), nodes (D), and ends (E).(F) Representative traces of membrane potential responding to step depolarization by current injection steps from −10 pA to +60 pA in 10-pA increments. Membrane potential was current-clamped at around -65 mV. Representative traces were displayed by WT neurons.(G) Quantification of the neuron maturity by recorded AP firing patterns at day 60 after differentiation (more than 15 neurons in every group have been recorded).(H) Representative traces of whole-cell currents in voltage-clamp mode. Cells were held at −70 mV. Step depolarization from −80 to +60 mV at 10-mV intervals was delivered. Inset shows Na^+^ currents.(I) Quantification of membrane capacitance in neurons at 60 days after differentiation. Error bars indicate ±SEM. ^∗^p \< 0.05; a two-tailed t test was performed.(J) Quantification of membrane resistance in neurons at 60 days after differentiation. ^∗^p \< 0.05.(K and L) Averaged current-voltage relationship (I-V curves) for Na^+^ currents, recorded from hESC-derived neurons. ns, not significant; ^∗^p \< 0.05, ^∗∗^p \< 0.01.(M and N) Averaged current-voltage relationship (I-V curves) for K^+^ currents, recorded from hESC-derived neurons. ns, not significant; ^∗^p \< 0.05, ^∗∗^p \< 0.01.

To further examine the effect of *UTX* loss of function on the maturity of hESC-derived neurons, we performed electrophysiological recordings of hESC-derived neurons in each group using whole-cell patch recordings at day 60 (ASV 0 nM, n = 28; 50 nM, n = 20; 100 nM, n = 26; 1,000 nM) ([Figure 4](#fig4){ref-type="fig"}F). We found that, in the WT group, 27.7% of the recorded mature action potential (AP) firing properties with faster and consistent AP velocity, and 36.1% fire single or fewer spikes of APs, 36.1% of the recorded cells fail to show spikes of APs ([Figure 4](#fig4){ref-type="fig"}G). As expected, the proportion of immature neurons and no-spike cells increased in both *UTX* KO1 (52.9%) and KO2 (68.7%) cell lines, again suggesting that loss of *UTX* affects the maturity of hESC-derived neurons ([Figure 4](#fig4){ref-type="fig"}G). Moreover, membrane resistance ([Figure 4](#fig4){ref-type="fig"}I), membrane capacitance ([Figure 4](#fig4){ref-type="fig"}J), and sodium/potassium current ([Figures 4](#fig4){ref-type="fig"}K--4N) exhibited downward trends in *UTX* KO hESC-derived neurons compared with the control cells, indicating that hESC-derived neurons lacking *UTX* have impaired electrophysiological features.

Loss of *UTX* Leads to an Abnormal Transcription Profile in hESC-Derived Neurons {#sec2.6}
--------------------------------------------------------------------------------

To understand the molecular mechanisms underlying the decreased neurite complexity and electrophysiological defects in *UTX* KO hESC-derived neurons, we performed RNA sequencing (RNA-seq) of hESC-derived neurons at day 40 after neural differentiation. RNA-seq data analysis showed that the transcription profile of *UTX* KO neurons was significantly different from that of control cells ([Figure S5](#mmc1){ref-type="supplementary-material"}A). The clustering analysis and principal-component analysis proved clear discrimination between the *UTX* KO group and the WT group, indicating that neurons displayed distinctly gene expression pattern under the loss of *UTX* ([Figures S5](#mmc1){ref-type="supplementary-material"}B and S5C). A total of 954 downregulated genes and 2,611 upregulated genes were identified in *UTX* KO neurons ([Figure S5](#mmc1){ref-type="supplementary-material"}A). Gene ontology analysis showed that upregulated genes in *UTX* KO neurons were enriched for several cellular biological processes, including extracellular matrix organization, bone development and mesenchymal cell differentiation, and transforming growth factor β (*TGF-β*) signaling pathway ([Figure 5](#fig5){ref-type="fig"}A). Meanwhile, downregulated genes in *UTX* KO neurons were enriched for neurotransmitter transport, signal release from synapse, and neuron fate commitment ([Figure 5](#fig5){ref-type="fig"}B). Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis further demonstrated that many downregulated genes in *UTX* KO neurons contributed to glutamatergic, dopaminergic, GABAergic, or cholinergic synapse pathway enrichment ([Figures S5](#mmc1){ref-type="supplementary-material"}D and S5E). In contrast, KEGG analysis showed that the upregulated genes in *UTX* KO neurons were enriched in the *TGF-β* signaling pathway ([Figures S5](#mmc1){ref-type="supplementary-material"}D and S5E), a well-known pathway which regulates a diverse range of biological processes during development and adult tissue homeostasis. Finally, we validated the differential expression of 25 genes which were randomly selected from genes positively participated in synaptic function ([Figure 5](#fig5){ref-type="fig"}D), neural development ([Figure 5](#fig5){ref-type="fig"}E), or *TGF-β* signaling pathway ([Figure 5](#fig5){ref-type="fig"}F) using qPCR. These results suggest that *UTX* is a critical regulator for human neural development and synaptic function.Figure 5*UTX* KO Neurons Have an Abnormal Gene Expression Profile that Is Related to the Development and Synaptic Function(A) Gene ontology terms enriched in genes upregulated in *UTX* KO-derived neurons.(B) Gene ontology terms enriched in genes downregulated in *UTX* KO-derived neurons.(C) Volcano plot of downregulated genes (blue) and upregulated genes (red) in *UTX* KO-derived neurons. Genes associated with *TGF-β* signaling pathway (*TGF-β1*, *TGF-β2*, *TGF-β3*) and neural function (*SLC6A1*, *SLC32A1*, *POU3F2*, *CAMK2A*) are indicated.(D) qPCR analysis verified that genes positively participated in synapse-related pathways were significantly downregulated in *UTX* KO neurons.(E) qPCR analysis verified that genes positively participated in neural development were significantly downregulated in *UTX* KO neurons.(F) qPCR analysis verified that genes positively participated in TGF-β signaling pathway were significantly upregulated in *UTX* KO neurons. Results are presented as mean ± SEM; n = at least 3 independent experiments. ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001. FC, fold change.

*UTX* KO Results in H3K27me3 Accumulation and H3K36me3 Reduction in hESC-Derived Neurons {#sec2.7}
----------------------------------------------------------------------------------------

To better understand the regulatory mechanism of *UTX* in hESC-derived neurons, we performed chromatin immunoprecipitation sequencing (ChIP-seq) to analyze the abundance of histone modifications in gene promoters. Meta-analysis of ChIP-seq data showed that both *UTX* KO and WT neurons displayed a broad distribution of H3K27me3 and H3K36me3 in promoters (±5 kb from the transcription start site \[TSS\]), and there was a slight reduction in H3K27me3, but an obvious reduction in H3K36me3 at the TSS regions ([Figures 6](#fig6){ref-type="fig"}A and [S6](#mmc1){ref-type="supplementary-material"}A). We then focused on 1,695 increased peaks of H3K27me3 enrichment ([Figure 6](#fig6){ref-type="fig"}B), and found these increased peaks most distributed in gene bodies and promoters ([Figure 6](#fig6){ref-type="fig"}C). Furthermore, gene set enrichment analysis showed these H3K27me3-gained regions tended to lose H3K36me3 enrichment ([Figures 6](#fig6){ref-type="fig"}D and [S6](#mmc1){ref-type="supplementary-material"}B). Reactome pathway enrichment analysis indicated these gained H3K27me3 peaks were mostly associated with neuronal system, voltage-gated potassium channel, and transmission across chemical synapses, and so on ([Figure 6](#fig6){ref-type="fig"}E). To further explore the regulatory mechanism of *UTX*, we performed conjoint data analysis of Chip-seq and RNA-seq, and found that there were 70 downregulated genes from RNA-seq analysis that gained H3K27me3 enrichment after the loss of *UTX* ([Figure 6](#fig6){ref-type="fig"}F). Moreover, odds ratio analysis and BETA plot of combined computational analysis showed that the decreased expression of these genes was obviously correlated with the gain of H3K27me3 ([Figures 6](#fig6){ref-type="fig"}G and [S6](#mmc1){ref-type="supplementary-material"}C). Gene ontology enrichment analysis of these 70 genes showed that they are involved in forebrain development, hindbrain development, neurotransmitter transport, and signal release from synapse ([Figure 6](#fig6){ref-type="fig"}H). *CKB* and *ASIC1* are important for neural development and synaptic function ([@bib16]; [@bib44]), and a reduced H3K36me3 enrichment and an increased H3K27me3 enrichment at promoters of these two genes were detected in *UTX* KO neurons compared with that of WT neurons. Therefore, our results demonstrated that *UTX* regulated transcription of genes associated with neural development and synaptic function depending on its demethylase.Figure 6The Gain of H3K27me3 Associates with the Reduction of Transcription in *UTX* KO Neurons(A) Average profiles of histone marks and input within ±5 kb of gene body of all GENCODE annotated genes.(B) Heatmaps of H3K27me3 peaks divided into increased enrichment (1,695 peaks) and decreased enrichment (1,306 peaks) group before and after *UTX* knockout separately.(C) Bar chart showing distribution of gained H3K27me3 peaks caused by *UTX* knockout at annotated genomic regions.(D) Gene set enrichment analysis of association between changes of H3K27me3 and H3K36me3 changes.(E) Reactome pathway enrichment analysis of genes with gained H3K27me3.(F) Venn diagram of a combined comparison of differentially expressed genes (RNA-up, upregulated genes; RNA-down, downregulated genes) and genes with different H3K27me3 enrichment (H3K27me3 gain, genes with increased H3K27me3 enrichment; H3K27me3 loss, genes with decreased H3K27me3 enrichment).(G) Odds ratio analysis of overlapping genes displaying differential histone H3K27me3 enrichment versus differential gene expression (DEx), insert numbers indicate respective p values for associations, with the number of genes overlapping in parentheses.(H) Gene ontology enrichment analysis of these 70 genes with increased H3K27me3 enrichment and downregulated expression. Displayed terms are all with an "p.adjust" \< 0.05.(I and J) Genome-browser view at *CKB* gene (I) and *ASIC1* (J) of different sequencing datasets.

*UTX* Acts as a Demethylase in Resolution and Activation of Bivalent Promoters during the Neural Differentiation of hESCs {#sec2.8}
-------------------------------------------------------------------------------------------------------------------------

Because H3K27 methyltransferase complex PRC2 was associated with the generation of bivalency ([@bib17]), we further assessed the effect of *UTX* loss on bivalent gene expression. Firstly, we used ChromHMM to model the chromatin states in NPCs, which included a bivalent promoter in the fifth row ([Figure 7](#fig7){ref-type="fig"}A, left), and analyzed the distribution of all promoters of differentiated genes after the loss of *UTX*. Because *EZH2* and CpG islands have been proven to be enriched in the bivalent promoters ([@bib4]; [@bib27]), we used them as positive controls. Interestingly, we found that different expressed genes between *UTX* KO and WT neurons, which could be divided into six groups: (1) RNA-up, (2) K27-down, (3) RNA-up and K27-down, (4) RNA-down, (5) K27-up, and (6) RNA-down and K27-up. Promoters of these six groups all belonged to bivalent promoters compared with control groups ([Figure 7](#fig7){ref-type="fig"}A, right). As the combination of transcription factors is also a key step in activating bivalent promoters, we then compared the 70 differentiated genes which belonged to RNA-down and K27-up groups with the *Homo sapiens* TF database, and found that 8 critical TFs were intersected, including *ASCL1*, *POU3F3*, and *POU3F4*, which are important for neural differentiation and morphogenesis ([Figure 7](#fig7){ref-type="fig"}B). We then compared the H3K27me3 changes of bivalent promoters of these 70 genes in *UTX* KO neurons and NPCs. Our results showed that the H3K27me3 enrichment decreased when *UTX* WT NPCs differentiated to neurons; however, the H3K27me3 enrichment level increased in differentiated *UTX* KO neurons ([Figure 7](#fig7){ref-type="fig"}C). The H3K36me3 enrichments in gene bodies of these 70 genes were also decreased in *UTX* KO neurons compared with WT neurons. These results indicated that *UTX* was involved in the resolution and activation of bivalent promoters during the neural differentiation of hESCs.Figure 7*UTX* Resolves Bivalent Promoters for the Induction of Lineage-Specific Genes during Human Neural Differentiation(A) Heatmap showing distribution of indicated groups of genomic regions on the chromatin states in NPCs modeled using ChromHMM (pro, promoters).(B) Venn diagram of a combined comparison of 70 genes with downregulated expression and H3K27me3 gain with TFs.(C) Left panel, boxplots showing changes of promoter H3K27me3 level of different conditions of 70 genes with downregulated expression and H3K27me3 gain; middle panel, boxplots showing changes of gene body H3K36me3 level of these genes; right panel, boxplots showing gene expression changes of these genes. (ChIP-seq and RNA-seq data of neural progenitor cell originated from H9 were downloaded from ENCODE \[<https://www.encodeproject.org/>, biosample: ENCBS044KWE\] and re-analyzed.)(D) A hypothetical model of *UTX* as a bivalency-resolving demethylase necessary for neural differentiation of hESCs.

Discussion {#sec3}
==========

Aberrant neural differentiation and dendritic morphogenesis in neurons are pervasive in many developmental brain disorders ([@bib21]; [@bib31]). Deletion of *UTX* results in increased anxiety-like behaviors and impaired spatial learning and memory in mice, and *UTX* deficiency in the hippocampus leads to reduced long-term potentiation and amplitude of miniature excitatory postsynaptic current, aberrant dendrite development, and defective synapse formation ([@bib40]). In this paper, we show that *UTX* regulates neural differentiation and dendritic morphology during the differentiation of hESCs into neurons by resolving bivalent promoters, partially through association with transcription factors. Deletion of *UTX* makes some bivalent promoters of critical genes associating with neural development to increase H3K27me3 and to reduce H3K36me3 to inhibit their transcription, which eventually causes defects in human neural differentiation, dendritic morphogenesis, and electrophysiological function ([Figure 7](#fig7){ref-type="fig"}D).

In the process of neurogenesis, we find that H3K27me3 levels were unchanged in the hESCs after the loss of *UTX*, and the differentiation potential of *UTX* KO hESCs to hNPCs is not affected. This finding supports the idea that maintaining the level of H3K27me3 may be important for the early stage of neurogenesis ([@bib35]).

There is a great debate on how *UTX* regulates gene transcription. Given the role of *UTX* in removal of repressive H3K27me3 to establish transcriptionally permissive chromatin, its demethylase activity is required for activating gene expression in T cells ([@bib25]), osteoblasts ([@bib46]), and myoblasts ([@bib11]). A previously published study reports that human *53BP1* contains a *UTX*-binding site and the *53BP1*-*UTX* interaction is required to upregulate key neurodevelopmental genes during the differentiation of hESCs into neurons ([@bib47]). In the present study, we provide more evidence to demonstrate that *UTX* not only regulates the transition of hNPCs to neurons, but also affects neural morphogenesis and synaptic function by resolving bivalent promoters. *UTX* has been reported necessary for the resolution and activation of numerous retinoic acid (RA)-inducible bivalent genes during the RA-driven differentiation of mouse embryonic stem cells ([@bib9]). Consistent with this, we also demonstrate that *UTX* plays an important role in human neural differentiation and neural morphology by regulating bivalent promoters.

Importantly, we find that *UTX* deficiency in hESC-derived neurons also causes transcriptional activation of dozens of genes, i.e., *TGF-β* signaling pathway-related genes, including *BMP4*, *TGF-β1*, *TGF-β2*, *TGF-β3*, and *ACVR1*, which negatively regulate neuronal morphogenesis ([@bib33]), and the inhibition of the TGF-β signaling pathway is important for the differentiation of hESCs to neurons ([@bib32]). How these genes are activated after the loss of *UTX* still needs to be studied. Interestingly, *EZH2* is downregulated in *UTX*-null hESC-derived neurons, we speculate that *EZH2* reduction may be responsible for the de-repression of upregulated genes during neural differentiation of *UTX*-null hESCs. For a better understanding of the complex regulatory mechanisms mediated by *UTX*, future studies are necessary to characterize chromatin structure and epigenetic modification by a higher resolution of both RNA and DNA sequencing.

Experimental Procedures {#sec4}
=======================

Maintenance and Differentiation of hESCs {#sec4.1}
----------------------------------------

The human H9 (WA09) ESC line was obtained from Dr. Baoyang Hu at the Institute of Zoology, Chinese Academy of Sciences. H9 cells were cultured on Matrigel (BD, New Jersey, USA) using TeSR-E8 (STEMCELL Technologies, Vancouver, BC, Canada) and passaged with EDTA (100  μM). Neural differentiation of the H9 cells was initiated by the formation of embryoid bodies (EBs) as described previously with minor modifications ([@bib19]). In brief, hESC colonies were dissociated with Accutase (BD) and resuspended as single cells in E8 medium with 10 μM Rock inhibitor (Y27632, Selleck, Shanghai, China). To produce EBs from hESCs, hESC medium was replaced with N2 medium (DMEMF/12, 1× N2, 1× NEAA) at day 3 and the medium was changed every other day. To obtain NPCs derived from hESCs, the EBs were plated at day 7 on Matrigel-coated plates with 1 μg/mL laminin (Life Technologies, Carlsbad, CA, USA) and cultured in N2 medium. NPCs in the form of rosettes were manually picked at day 14 and expanded as neurospheres in N2B27 medium (DMEM/F12, 1× N2, 1× B27, 0.2 μM RA, and 20 ng/mL fibroblast growth factor 2) until day 20. For neuronal differentiation, the dissociated NPCs at day 20 were plated onto poly-L-ornithine/laminin (50 μg/mL)-coated coverslips, and cultured in neuronal differentiation medium (DMEM/F12, 1× N2, 1× B27, 10 ng/mL brain-derived neurotrophic factor, 10 ng/mL GDNF, 1 mM dibutyryl-cyclic AMP, and 200 nM ascorbic acid).

Construction of the RNA-Guided CRISPR/Cas9 Vector {#sec4.2}
-------------------------------------------------

Two specific guide RNA sequences (sgRNAs) targeting exon 1 of *UTX* were designed at the Optimized CRISPR Design website (<http://crispr.mit.edu>) ([@bib7]). Then, the two guide RNA sequences were respectively annealed and cloned to the PX330-GFP-U6 plasmid (a gift from Dr. Haoyi Wang at the Institute of Zoology, Chinese Academy of Sciences) to generate all-in-one expression vector containing two sgRNA expression cassettes.

CRISPR/Cas9-Mediated KO of UTX in hESCs {#sec4.3}
---------------------------------------

H9 cells were dissociated into single cells using Accutase at 37°C for 5 min. Cells (2 × 10^6^) were electroporated with 10 μg *UTX* double-guide RNA expression plasmid using Human Stem Cell Nucleofector kit 2 (Lonza) with program CM115 in a Nucleofector II device. Cells were resuspended in hESC medium supplemented with 10 μM Rock inhibitor (Y-27632) and re-plated on Matrigel-coated plates. After 36 h of culture, GFP-positive cells were selected with flow cytometry and reseeded as single cells. Approximately 2 weeks later, colonies were singly picked and expanded for genotype sequencing.

Histone Extraction {#sec4.4}
------------------

Histones were isolated from cells by following a standard acid extraction protocol ([@bib36]). In brief, the cells were suspended with hypotonic lysis buffer and blown into single cells. Then the cells were shaken at 4°C for 30 min and centrifuged at 10,000 × *g* for 10 min at 4°C. Supernatant was discarded and the nuclei pellet was resuspended in 0.4 N H~2~SO~4.~ Then the nucleic solution was centrifuged and supernatant was collected, and 132 μL tricarboxylic acid (TCA) was added drop by drop to histone solution and the tube was inverted several times to mix the solutions (the final concentration of TCA was 33%). The precipitate was centrifuged, collected and washed with acetone twice. Finally, histone was dissolved with 4 M urea.

Proliferation Analysis of Cultured NPCs {#sec4.5}
---------------------------------------

To examine the proliferation ability of NPCs, EBs at day 7 of culture were plated on Matrigel-coated coverslips. After 7 days of differentiation, 5 μM BrdU (Sigma-Aldrich, St. Louis, MO, USA) was added to the culture medium for 3.5 h. NPCs were then fixed with 4% paraformaldehyde for 20 min at room temperature, and finally washed with 1× PBS, followed by BrdU immunostaining.

*In Vitro* Analysis of Dendritic Morphology {#sec4.6}
-------------------------------------------

For quantitative analysis of dendrites, neurons at day 40 in culture were fixed with 4% paraformaldehyde and then washed with PBS *in vitro*. Fixed neurons were blocked and permeabilized with 2% normal goat serum/0.1% Triton X-100 for 1 h at room temperature. Neurons were incubated with anti-Map2 antibody (cat. no. 822501, BioLegend, 1:1,000) overnight at 4°C, and then incubated with secondary antibody for 1 h at room temperature. Images of the dendrites were acquired using a Zeiss LSM710 confocal microscope with a 40× lens. Dendritic branches were traced, and their lengths were calculated using the Simple Neurite Tracer plugin of Fiji.

Western Blot Analysis {#sec4.7}
---------------------

Cell pellets were lysed in RIPA lysis buffer (Thermo Fisher Scientific, Waltham, MA, USA) supplemented with protease inhibitor (Roche Applied Science), and samples were then quantified using a BCA protein assay kit (Thermo Fisher Scientific). After electrophoresis, proteins were transferred onto nitrocellulose membranes. The following primary antibodies were used: UTX (cat no. GTX121246, GeneTex, 1:2,000), JMJD3 (cat no. GTX124222, GeneTex 1:1,000), Oct-3/4 (cat no. sc-5279 Santa Cruz 1:1,000), and NANOG (cat no. 14295-1 Proteintech 1:1,000).

Electrophysiological Recordings {#sec4.8}
-------------------------------

Whole-cell current and clamp recordings were performed at 22°C in artificial cerebral spinal fluid, bubbled with 95% O~2~ and 5% CO~2~. The extracellular fluid consisted of: 124 mM NaCl, 3.3 mM KCl, 2.4 mM MgSO~4~, 1.2 mM KH~2~PO~4~, 26 mM NaHCO~3~, 2.5 mM CaCl~2~, and 10 mM glucose (pH 7.4). Borosilicate glass electrodes (resistance 6--10 MΩ) were filled with an intracellular solution containing 135 mM potassium gluconate, 7 mM NaCl, 10 mM HEPES, 2 mM MgATP, 0.3 mM Na~2~GTP, and 2 mM MgCl~2~, adjusted to pH 7.4 with KOH. Cell visualization and patch pipette micromanipulation were performed by video-microscopy, using a 40× water-immersion objective mounted on an upright microscope equipped with infrared differential interference contrast (Nikon, Eclipse fn1, Japan). Intracellular membrane electrical potentials were recorded in current-clamp mode, using a Multi-clamp 700B amplifier (Molecular Devices, Palo Alto, CA, USA). For voltage-clamp recordings, cells were held at −70 mV. All compounds were obtained from Sigma (St. Louis, MO). Data were digitized at 10 kHz with a 2-kHz low-pass filter. Data processing and analysis were performed using Clampfit 10.6 (Axon Instruments).

RNA Isolation and qRT-PCR {#sec4.9}
-------------------------

Total RNA was extracted with TRIzol (Invitrogen, New York, UK) and then was reverse-transcribed into cDNA using the TransScript One-Step gDNA Removal and cDNA Synthesis SuperMix Kit (cat no. 20200725 TRAN). Real-time qPCR was performed using the Super Real PreMix Plus (SYBR Green I) (Takara) in a 20-μL reaction system on the Roche LightCycler\@480II. ACTB was used as endogenous control to normalize the RNA content of samples. The primers we used were listed in [Table S1](#mmc1){ref-type="supplementary-material"}. The relative expression level of each mRNA was analyzed by the ΔΔCT method. All experiments were repeated at least in triplicate.

Statistical Analysis {#sec4.10}
--------------------

Experiments were conducted in at least three biological replicates for each group. For statistical analyses, unpaired two-tailed Student\'s t tests (two groups) or ANOVA (three or more groups) were performed using GraphPad Prism 6.0 software. All data were presented as mean ± SEM. Differences of p \< 0.05 were considered statistically significant.

Data and Code Availability {#sec4.11}
--------------------------

The RNA-seq and ChIP-seq data presented in this manuscript are accessible through GEO series accession number GEO: [GSE152448](ncbi-geo:GSE152448){#intref0020}.
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